Global Pharmaceutical & Biotechnology Environmental Monitoring

Pharmaceutical & Biotechnology Environmental Monitoring Comprehensive Study by Type (Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others), Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others), Software, Microbiology Services), Application (Surface Monitoring, Personnel Monitoring, Air Monitoring), End User (Pharmaceutical Companies, Biotechnology Companies, CRO & CMOs, Academic & Research Institutes, Others) Players and Region - Global Market Outlook to 2028

Pharmaceutical & Biotechnology Environmental Monitoring Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Pharmaceutical & Biotechnology Environmental Monitoring
Pharmaceutical & biotechnology environmental monitoring is the crucial part of the manufacturing process in order to indicate that the microbial and particulate content of all clean room air and work surfaces are below acceptable levels. It also represents a vital means by which the effectiveness of contamination control measures can be assessed and the specific threats to the purity of products being manufactured can be identified.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The key players are targeting the innovations of the Solutions with better quality, and better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking about mergers and acquisitions in order to maintain their presence in the market. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Pharmaceutical & Biotechnology Environmental Monitoring market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Danaher Corporation (United States), Thermo Fisher Scientific (United States), Merck KGaA (Germany), Sinensis Life Sciences B.V. (Netherlands), Lonza Group Ltd (Switzerland), Biomerieux (United States), Veltek Associates, Inc. (United States), Cosasco (United States), RMONI (Belgium), Amphenol Advanced Sensors (Germany), Vaisala (Finland), Eurofins Scientific SE (Luxembourg), Ellab Monitoring Solutions Ltd. (United Kingdom), Sartorius AG (Germany) and Novatek International (Canada) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Pharmaceutical & Biotechnology Environmental Monitoring market by Type (Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others), Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others), Software and Microbiology Services), Application (Surface Monitoring, Personnel Monitoring and Air Monitoring) and Region.



On the basis of geography, the market of Pharmaceutical & Biotechnology Environmental Monitoring has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Pharmaceutical Companies will boost the Pharmaceutical & Biotechnology Environmental Monitoring market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technological Advancements in Environmental Monitoring Products

Market Growth Drivers:
The Stringent Government Regulations Regarding Manufacturing process of Pharmaceutical & Biotechnological Products, The Growing Pharmaceutical & Biotechnology Industry Worldwide and The Rising Cases of Microbial Contamination & Product Recalls

Challenges:
Maintaining Sterility or Purity of the Desired Organism

Restraints:
Stringent Regulations and High Cost of Pharmaceutical & Biotechnology Environmental Monitoring Solutions

Opportunities:
The Emerging Demand from Economies

On 2 April 2019, G-CON Manufacturing, the leader in prefabricated, flexible cleanroom solutions, and Veltek Associates, a leader in solutions for the control of particulate and microbial contamination, announced that the two companies have signed a distribution agreement whereby G-CON will distribute Veltek’s cleanroom products systems and services to G-CON’s customers. Through this relationship, G-CON and Veltek will be able to provide a turnkey prefabricated cleanroom, cleaning products, gowning materials, cleanroom equipment, and cleanroom expertise.


Key Target Audience
Environmental Monitoring Equipment Manufacturers, Environmental Monitoring Equipment Traders/Distributors, Environmental Monitoring Equipment Importer/Exporter, Software Providers, Services Providers, Regulatory & Government Bodies, End Users and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others)
  • Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others)
  • Software
  • Microbiology Services
By Application
  • Surface Monitoring
  • Personnel Monitoring
  • Air Monitoring
By End User
  • Pharmaceutical Companies
  • Biotechnology Companies
  • CRO & CMOs
  • Academic & Research Institutes
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Stringent Government Regulations Regarding Manufacturing process of Pharmaceutical & Biotechnological Products
      • 3.2.2. The Growing Pharmaceutical & Biotechnology Industry Worldwide
      • 3.2.3. The Rising Cases of Microbial Contamination & Product Recalls
    • 3.3. Market Challenges
      • 3.3.1. Maintaining Sterility or Purity of the Desired Organism
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in Environmental Monitoring Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharmaceutical & Biotechnology Environmental Monitoring, by Type, Application, End User and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Pharmaceutical & Biotechnology Environmental Monitoring (Value)
      • 5.2.1. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Type (Value)
        • 5.2.1.1. Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others)
        • 5.2.1.2. Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others)
        • 5.2.1.3. Software
        • 5.2.1.4. Microbiology Services
      • 5.2.2. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Application (Value)
        • 5.2.2.1. Surface Monitoring
        • 5.2.2.2. Personnel Monitoring
        • 5.2.2.3. Air Monitoring
      • 5.2.3. Global Pharmaceutical & Biotechnology Environmental Monitoring by: End User (Value)
        • 5.2.3.1. Pharmaceutical Companies
        • 5.2.3.2. Biotechnology Companies
        • 5.2.3.3. CRO & CMOs
        • 5.2.3.4. Academic & Research Institutes
        • 5.2.3.5. Others
      • 5.2.4. Global Pharmaceutical & Biotechnology Environmental Monitoring Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pharmaceutical & Biotechnology Environmental Monitoring (Price)
      • 5.3.1. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Type (Price)
  • 6. Pharmaceutical & Biotechnology Environmental Monitoring: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danaher Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Thermo Fisher Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck KGaA (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sinensis Life Sciences B.V. (Netherlands)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Lonza Group Ltd (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Biomerieux (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Veltek Associates, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cosasco (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. RMONI (Belgium)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Amphenol Advanced Sensors (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Vaisala (Finland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Eurofins Scientific SE (Luxembourg)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Ellab Monitoring Solutions Ltd. (United Kingdom)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Sartorius AG (Germany)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Novatek International (Canada)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Pharmaceutical & Biotechnology Environmental Monitoring Sale, by Type, Application, End User and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Pharmaceutical & Biotechnology Environmental Monitoring (Value)
      • 7.2.1. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Type (Value)
        • 7.2.1.1. Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others)
        • 7.2.1.2. Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others)
        • 7.2.1.3. Software
        • 7.2.1.4. Microbiology Services
      • 7.2.2. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Application (Value)
        • 7.2.2.1. Surface Monitoring
        • 7.2.2.2. Personnel Monitoring
        • 7.2.2.3. Air Monitoring
      • 7.2.3. Global Pharmaceutical & Biotechnology Environmental Monitoring by: End User (Value)
        • 7.2.3.1. Pharmaceutical Companies
        • 7.2.3.2. Biotechnology Companies
        • 7.2.3.3. CRO & CMOs
        • 7.2.3.4. Academic & Research Institutes
        • 7.2.3.5. Others
      • 7.2.4. Global Pharmaceutical & Biotechnology Environmental Monitoring Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pharmaceutical & Biotechnology Environmental Monitoring (Price)
      • 7.3.1. Global Pharmaceutical & Biotechnology Environmental Monitoring by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharmaceutical & Biotechnology Environmental Monitoring: by Type(USD Million)
  • Table 2. Pharmaceutical & Biotechnology Environmental Monitoring Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others) , by Region USD Million (2017-2022)
  • Table 3. Pharmaceutical & Biotechnology Environmental Monitoring Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others) , by Region USD Million (2017-2022)
  • Table 4. Pharmaceutical & Biotechnology Environmental Monitoring Software , by Region USD Million (2017-2022)
  • Table 5. Pharmaceutical & Biotechnology Environmental Monitoring Microbiology Services , by Region USD Million (2017-2022)
  • Table 6. Pharmaceutical & Biotechnology Environmental Monitoring: by Application(USD Million)
  • Table 7. Pharmaceutical & Biotechnology Environmental Monitoring Surface Monitoring , by Region USD Million (2017-2022)
  • Table 8. Pharmaceutical & Biotechnology Environmental Monitoring Personnel Monitoring , by Region USD Million (2017-2022)
  • Table 9. Pharmaceutical & Biotechnology Environmental Monitoring Air Monitoring , by Region USD Million (2017-2022)
  • Table 10. Pharmaceutical & Biotechnology Environmental Monitoring: by End User(USD Million)
  • Table 11. Pharmaceutical & Biotechnology Environmental Monitoring Pharmaceutical Companies , by Region USD Million (2017-2022)
  • Table 12. Pharmaceutical & Biotechnology Environmental Monitoring Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 13. Pharmaceutical & Biotechnology Environmental Monitoring CRO & CMOs , by Region USD Million (2017-2022)
  • Table 14. Pharmaceutical & Biotechnology Environmental Monitoring Academic & Research Institutes , by Region USD Million (2017-2022)
  • Table 15. Pharmaceutical & Biotechnology Environmental Monitoring Others , by Region USD Million (2017-2022)
  • Table 16. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2017-2022)
  • Table 17. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 18. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 19. South America Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 20. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 21. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 22. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 23. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 24. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 25. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 26. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 28. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 29. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2017-2022)
  • Table 30. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 31. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 32. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 33. China Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 34. China Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 35. China Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 36. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 37. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 38. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 39. India Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 40. India Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 41. India Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 42. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 43. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 44. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 45. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 46. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 47. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 48. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 49. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 50. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 53. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 54. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2017-2022)
  • Table 55. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 56. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 57. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 58. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 59. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 60. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 61. France Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 62. France Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 63. France Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 64. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 65. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 66. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 67. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 68. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 69. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 70. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 71. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 72. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 73. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 74. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 75. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 76. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2017-2022)
  • Table 77. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 78. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 79. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 80. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 81. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 82. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 83. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 84. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 85. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 86. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2017-2022)
  • Table 87. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 88. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 89. North America Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 90. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 91. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 92. United States Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 93. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 94. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 95. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 96. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2017-2022)
  • Table 97. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2017-2022)
  • Table 98. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2017-2022)
  • Table 99. Pharmaceutical & Biotechnology Environmental Monitoring: by Type(USD/Units)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Pharmaceutical & Biotechnology Environmental Monitoring: by Type(USD Million)
  • Table 116. Pharmaceutical & Biotechnology Environmental Monitoring Monitoring Equipment (Particle Counters, Air Samplers, Temperature/ Humidity Monitors, Microbial Identification Systems, Isolators and RABS, Others) , by Region USD Million (2023-2028)
  • Table 117. Pharmaceutical & Biotechnology Environmental Monitoring Consumables (Media, Plates, Reagent & Kits, Swabs, Contact Slides, Others) , by Region USD Million (2023-2028)
  • Table 118. Pharmaceutical & Biotechnology Environmental Monitoring Software , by Region USD Million (2023-2028)
  • Table 119. Pharmaceutical & Biotechnology Environmental Monitoring Microbiology Services , by Region USD Million (2023-2028)
  • Table 120. Pharmaceutical & Biotechnology Environmental Monitoring: by Application(USD Million)
  • Table 121. Pharmaceutical & Biotechnology Environmental Monitoring Surface Monitoring , by Region USD Million (2023-2028)
  • Table 122. Pharmaceutical & Biotechnology Environmental Monitoring Personnel Monitoring , by Region USD Million (2023-2028)
  • Table 123. Pharmaceutical & Biotechnology Environmental Monitoring Air Monitoring , by Region USD Million (2023-2028)
  • Table 124. Pharmaceutical & Biotechnology Environmental Monitoring: by End User(USD Million)
  • Table 125. Pharmaceutical & Biotechnology Environmental Monitoring Pharmaceutical Companies , by Region USD Million (2023-2028)
  • Table 126. Pharmaceutical & Biotechnology Environmental Monitoring Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 127. Pharmaceutical & Biotechnology Environmental Monitoring CRO & CMOs , by Region USD Million (2023-2028)
  • Table 128. Pharmaceutical & Biotechnology Environmental Monitoring Academic & Research Institutes , by Region USD Million (2023-2028)
  • Table 129. Pharmaceutical & Biotechnology Environmental Monitoring Others , by Region USD Million (2023-2028)
  • Table 130. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2023-2028)
  • Table 131. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 132. South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 133. South America Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 134. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 135. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 136. Brazil Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 137. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 138. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 139. Argentina Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 140. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 141. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 142. Rest of South America Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 143. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2023-2028)
  • Table 144. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 145. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 146. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 147. China Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 148. China Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 149. China Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 150. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 151. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 152. Japan Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 153. India Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 154. India Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 155. India Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 156. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 157. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 158. South Korea Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 159. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 160. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 161. Taiwan Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 162. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 163. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 164. Australia Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 165. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 166. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 167. Rest of Asia-Pacific Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 168. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2023-2028)
  • Table 169. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 170. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 171. Europe Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 172. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 173. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 174. Germany Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 175. France Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 176. France Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 177. France Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 178. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 179. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 180. Italy Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 181. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 182. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 183. United Kingdom Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 184. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 185. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 186. Netherlands Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 187. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 188. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 189. Rest of Europe Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 190. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2023-2028)
  • Table 191. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 192. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 193. MEA Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 194. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 195. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 196. Middle East Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 197. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 198. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 199. Africa Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 200. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Country USD Million (2023-2028)
  • Table 201. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 202. North America Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 203. North America Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 204. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 205. United States Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 206. United States Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 207. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 208. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 209. Canada Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 210. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Type USD Million (2023-2028)
  • Table 211. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by Application USD Million (2023-2028)
  • Table 212. Mexico Pharmaceutical & Biotechnology Environmental Monitoring, by End User USD Million (2023-2028)
  • Table 213. Pharmaceutical & Biotechnology Environmental Monitoring: by Type(USD/Units)
  • Table 214. Research Programs/Design for This Report
  • Table 215. Key Data Information from Secondary Sources
  • Table 216. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Type USD Million (2017-2022)
  • Figure 5. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Application USD Million (2017-2022)
  • Figure 6. Global Pharmaceutical & Biotechnology Environmental Monitoring: by End User USD Million (2017-2022)
  • Figure 7. South America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 8. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 9. Europe Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 10. MEA Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 11. North America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 12. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Type USD/Units (2017-2022)
  • Figure 13. Global Pharmaceutical & Biotechnology Environmental Monitoring share by Players 2022 (%)
  • Figure 14. Global Pharmaceutical & Biotechnology Environmental Monitoring share by Players (Top 3) 2022(%)
  • Figure 15. Global Pharmaceutical & Biotechnology Environmental Monitoring share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Danaher Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Danaher Corporation (United States) Revenue: by Geography 2022
  • Figure 19. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher Scientific (United States) Revenue: by Geography 2022
  • Figure 21. Merck KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 22. Merck KGaA (Germany) Revenue: by Geography 2022
  • Figure 23. Sinensis Life Sciences B.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 24. Sinensis Life Sciences B.V. (Netherlands) Revenue: by Geography 2022
  • Figure 25. Lonza Group Ltd (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Lonza Group Ltd (Switzerland) Revenue: by Geography 2022
  • Figure 27. Biomerieux (United States) Revenue, Net Income and Gross profit
  • Figure 28. Biomerieux (United States) Revenue: by Geography 2022
  • Figure 29. Veltek Associates, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. Veltek Associates, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. Cosasco (United States) Revenue, Net Income and Gross profit
  • Figure 32. Cosasco (United States) Revenue: by Geography 2022
  • Figure 33. RMONI (Belgium) Revenue, Net Income and Gross profit
  • Figure 34. RMONI (Belgium) Revenue: by Geography 2022
  • Figure 35. Amphenol Advanced Sensors (Germany) Revenue, Net Income and Gross profit
  • Figure 36. Amphenol Advanced Sensors (Germany) Revenue: by Geography 2022
  • Figure 37. Vaisala (Finland) Revenue, Net Income and Gross profit
  • Figure 38. Vaisala (Finland) Revenue: by Geography 2022
  • Figure 39. Eurofins Scientific SE (Luxembourg) Revenue, Net Income and Gross profit
  • Figure 40. Eurofins Scientific SE (Luxembourg) Revenue: by Geography 2022
  • Figure 41. Ellab Monitoring Solutions Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. Ellab Monitoring Solutions Ltd. (United Kingdom) Revenue: by Geography 2022
  • Figure 43. Sartorius AG (Germany) Revenue, Net Income and Gross profit
  • Figure 44. Sartorius AG (Germany) Revenue: by Geography 2022
  • Figure 45. Novatek International (Canada) Revenue, Net Income and Gross profit
  • Figure 46. Novatek International (Canada) Revenue: by Geography 2022
  • Figure 47. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Type USD Million (2023-2028)
  • Figure 48. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Application USD Million (2023-2028)
  • Figure 49. Global Pharmaceutical & Biotechnology Environmental Monitoring: by End User USD Million (2023-2028)
  • Figure 50. South America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 51. Asia Pacific Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 52. Europe Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 53. MEA Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 54. North America Pharmaceutical & Biotechnology Environmental Monitoring Share (%), by Country
  • Figure 55. Global Pharmaceutical & Biotechnology Environmental Monitoring: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Danaher Corporation (United States)
  • Thermo Fisher Scientific (United States)
  • Merck KGaA (Germany)
  • Sinensis Life Sciences B.V. (Netherlands)
  • Lonza Group Ltd (Switzerland)
  • Biomerieux (United States)
  • Veltek Associates, Inc. (United States)
  • Cosasco (United States)
  • RMONI (Belgium)
  • Amphenol Advanced Sensors (Germany)
  • Vaisala (Finland)
  • Eurofins Scientific SE (Luxembourg)
  • Ellab Monitoring Solutions Ltd. (United Kingdom)
  • Sartorius AG (Germany)
  • Novatek International (Canada)
Select User Access Type

Key Highlights of Report


Oct 2023 206 Pages 80 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pharmaceutical & Biotechnology Environmental Monitoring Quantitative research analysis
Global Pharmaceutical & Biotechnology Environmental Monitoring Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Danaher Corporation (United States), Thermo Fisher Scientific (United States), Merck KGaA (Germany), Sinensis Life Sciences B.V. (Netherlands), Lonza Group Ltd (Switzerland), Biomerieux (United States), Veltek Associates, Inc. (United States), Cosasco (United States), RMONI (Belgium), Amphenol Advanced Sensors (Germany), Vaisala (Finland), Eurofins Scientific SE (Luxembourg), Ellab Monitoring Solutions Ltd. (United Kingdom), Sartorius AG (Germany) and Novatek International (Canada) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technological Advancements in Environmental Monitoring Products" is seen as one of major influencing trends for Pharmaceutical & Biotechnology Environmental Monitoring Market during projected period 2022-2028.
The Pharmaceutical & Biotechnology Environmental Monitoring market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Pharmaceutical & Biotechnology Environmental Monitoring Report?

Have a Query? Click Here

Other Related Reports

Allergy Medicine Comprehensive Study by Type (Tablet, Liquid), Allergy (Drug Allergy, Food Allergy, Skin Allergy, Insect Allergy, Latex Allergy, Others), Symptoms (Hives, Fever) Players and Region -...
$ 3500
Metronidazole Comprehensive Study by Type (Metronidazole Tablets, Metronidazole Capsule, Metronidazole Injection, Others), Application (Anaerobic Bacterial Infections, Sexually Transmitted Disease, B...
$ 3750
Botox Comprehensive Study by Type (Botulinum Toxin Type A, Botulinum Toxin Type B), Application (Aesthetic Use, Therapeutics Use), End User (Clinics) Players and Region - Global Market Outlook to 202...
$ 3500
Ampoules Packaging Comprehensive Study by Type (Polyvinyl Chloride, Polyethylene Terephthalate, High Impact Polystyrene), Application (Pharmaceuticals, Personal Care, Chemical, Others), Category (Gla...
$ 3800
Wound Care Dressing Comprehensive Study by Type (Hydrocolloid, Hydrogel, Alginate, Collagen, Others), Application (Acute wounds, Chronic Wounds, Surgical Wounds) Players and Region - Global Market Ou...
$ 3500
Intravenous Iron Drugs Comprehensive Study by Type (Ferric Gluconate, Ferric Carboxyl Maltose, Iron Sucrose, Iron Dextran), Application (Adult, Paediatric), Distribution Channel (Hospital Pharmacies,...
$ 3650